Vivanza Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 17, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	78	70	80	272	752	755
Market Cap Growth	-7.14%	-11.56%	-70.69%	-63.88%	-0.34%	44.45%
Enterprise Value	179	166	140	322	807	784
Last Close Price	1.95	1.76	1.99	6.79	18.80	18.86
PE Ratio	16.20	17.85	-	49.63	125.69	226.61
PS Ratio	0.07	0.06	1.07	0.97	4.14	6.74
PB Ratio	1.79	1.62	2.01	5.86	18.38	21.61
P/TBV Ratio	2.86	2.59	3.42	9.05	30.62	40.63
P/FCF Ratio	-	-	-	13.54	-	30.59
P/OCF Ratio	-	-	-	13.29	-	30.59
EV/Sales Ratio	0.15	0.14	1.88	1.16	4.44	7.00
EV/EBITDA Ratio	18.45	19.62	-	28.78	70.90	91.48
EV/EBIT Ratio	18.91	20.14	-	29.10	71.06	92.28
EV/FCF Ratio	-	-	-	16.07	-	31.78
Debt / Equity Ratio	2.34	2.34	2.18	1.12	1.96	1.58
Debt / EBITDA Ratio	10.49	12.07	-	4.61	7.03	6.43
Debt / FCF Ratio	-	-	-	2.58	-	2.23
Net Debt / Equity Ratio	2.32	2.32	2.15	1.07	1.91	1.56
Net Debt / EBITDA Ratio	10.42	11.99	-29.22	4.44	6.88	6.36
Net Debt / FCF Ratio	-	-3.75	-3.39	2.48	-8.28	2.21
Asset Turnover	-	6.02	0.42	1.33	0.96	0.93
Inventory Turnover	-	39.36	3.20	11.58	6.73	6.26
Quick Ratio	-	0.74	0.90	0.96	0.75	0.83
Current Ratio	-	1.13	1.35	1.29	1.15	1.31
Return on Equity (ROE)	-	9.48%	-15.67%	12.54%	15.78%	10.01%
Return on Assets (ROA)	-	2.67%	-1.06%	3.30%	3.73%	4.42%
Return on Invested Capital (ROIC)	4.65%	4.43%	-2.76%	8.11%	9.09%	10.91%
Return on Capital Employed (ROCE)	-	15.70%	-4.20%	15.10%	20.50%	14.00%
Earnings Yield	5.82%	5.60%	-8.47%	2.02%	0.80%	0.44%
FCF Yield	-34.66%	-38.40%	-31.49%	7.39%	-1.26%	3.27%
Buyback Yield / Dilution	8.04%	1.40%	-2.32%	2.27%	-	-